Volume 366, Issue 9484, Pages (August 2005)

Slides:



Advertisements
Similar presentations
Start or Switch?: Latest data from ABCSG/ARNO
Advertisements

Extended adjuvant treatment with anastrozole: results from the ABCSG Trial 6a R Jakesz, H Samonigg, R Greil, M Gnant, M Schmid, W Kwasny, E Kubista, B.
Lectures inEarly Breast Cancer A PowerPoint slide set based on images from: Lectures in Early Breast Cancer Part 3: Adjuvant Therapy in Early Breast Cancer.
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials The Lancet Volume 386, Issue.
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Volume 14, Issue 12, Pages (November 2013)
Volume 370, Issue 9586, Pages (August 2007)
Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm,
Volume 12, Issue 9, Pages (September 2011)
Volume 356, Issue 9239, Pages (October 2000)
Volume 18, Issue 6, Pages (June 2017)
Volume 12, Issue 11, Pages (October 2011)
Volume 376, Issue 9747, Pages (October 2010)
Volume 387, Issue 10021, Pages (February 2016)
Figure 2. A consort diagram showing the flowchart of the trial
Volume 388, Issue 10058, Pages (November 2016)
Thank God for Richard Dawkins?
Benefits of switching postmenopausal women with hormone-sensitive early breast cancer to anastrozole after 2 years adjuvant tamoxifen: Combined results.
Volume 378, Issue 9804, Pages (November 2011)
Volume 5, Issue 4, Pages (April 2006)
Volume 377, Issue 9783, Pages (June 2011)
Volume 13, Issue 12, Pages (December 2012)
Intraoperative radiotherapy for early breast cancer
Volume 366, Issue 9503, Pages (December 2005)
Volume 9, Issue 12, Pages (December 2008)
Volume 392, Issue 10145, Pages (August 2018)
Volume 375, Issue 9732, Pages (June 2010)
Volume 374, Issue 9707, Pages (December 2009)
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Volume 13, Issue 11, Pages (November 2012)
Volume 2, Issue 12, Pages (December 2015)
Volume 372, Issue 9642, Pages (September 2008)
Volume 365, Issue 9466, Pages (April 2005)
Adjuvant chemotherapy for rectal cancer – Authors' reply
Volume 9, Issue 10, Pages (October 2008)
ABSTRACT ABCSG 6a MA17-1 MA.17R NSABP B-33. Extended Adjuvant Therapy With Aromatase Inhibitor Among Postmenopausal Breast Cancer.
Volume 386, Issue 10001, Pages (October 2015)
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised.
Volume 13, Issue 12, Pages (December 2012)
Volume 386, Issue 10001, Pages (October 2015)
Volume 11, Issue 4, Pages (April 2010)
Volume 14, Issue 11, Pages (October 2013)
Volume 12, Issue 8, Pages (August 2013)
Volume 385, Issue 9962, Pages (January 2015)
Volume 373, Issue 9676, Pages (May 2009)
Volume 388, Issue 10058, Pages (November 2016)
Volume 371, Issue 9627, Pages (May 2008)
Volume 387, Issue 10021, Pages (February 2016)
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials 
Volume 9, Issue 4, Pages (April 2008)
Volume 15, Issue 13, Pages (December 2014)
Volume 5, Issue 4, Pages (April 2018)
Volume 375, Issue 9726, Pages (May 2010)
Thank God for Richard Dawkins?
Volume 373, Issue 9658, Pages (January 2009)
Volume 373, Issue 9658, Pages (January 2009)
Volume 375, Issue 9714, Pages (February 2010)
Volume 12, Issue 8, Pages (August 2013)
ACST: which subgroups will benefit most from carotid endarterectomy?
Volume 371, Issue 9618, Pages (March 2008)
Characteristics of Malignant Pleural Mesothelioma in Women
Arlene Chan, Marc Buyse, Bin Yao  The Lancet Oncology 
Volume 375, Issue 9715, Pages (February 2010)
Steven A Narod  The Lancet  Volume 349, Issue 9068, (June 1997)
Volume 376, Issue 9747, Pages (October 2010)
Volume 14, Issue 9, Pages (August 2013)
Volume 12, Issue 1, Pages (January 2011)
Recurrence after low-dose radioiodine ablation and recombinant human thyroid- stimulating hormone for differentiated thyroid cancer (HiLo): long-term results.
Pleurodesis for primary spontaneous pneumothorax – Authors' reply
Volume 20, Issue 8, Pages (August 2019)
Presentation transcript:

Volume 366, Issue 9484, Pages 455-462 (August 2005) Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial  Prof Raimund Jakesz, MD, Prof Walter Jonat, MD, Prof Michael Gnant, MD, Prof Martina Mittlboeck, PhD, Prof Richard Greil, MD, Christoph Tausch, MD, Prof Joern Hilfrich, MD, Werner Kwasny, MD, Prof Christian Menzel, MD, Prof Hellmut Samonigg, MD, Prof Michael Seifert, MD, Prof Guenther Gademann, MD, Prof Manfred Kaufmann, MD  The Lancet  Volume 366, Issue 9484, Pages 455-462 (August 2005) DOI: 10.1016/S0140-6736(05)67059-6 Copyright © 2005 Elsevier Ltd Terms and Conditions

Figure 1 Trial profile The Lancet 2005 366, 455-462DOI: (10.1016/S0140-6736(05)67059-6) Copyright © 2005 Elsevier Ltd Terms and Conditions

Figure 2 Kaplan-Meier curves of event-free survival 0 timepoint=2 years after surgery. SD at 3 years: tamoxifen=0·81, anastrozole=0·65 The Lancet 2005 366, 455-462DOI: (10.1016/S0140-6736(05)67059-6) Copyright © 2005 Elsevier Ltd Terms and Conditions

Figure 3 HR (95%CI) for anastrozole versus tamoxifen stratified by nodal status, tumour grade, age, and hormone receptor status ER=oestrogen receptor; PgR=progesterone receptor. The Lancet 2005 366, 455-462DOI: (10.1016/S0140-6736(05)67059-6) Copyright © 2005 Elsevier Ltd Terms and Conditions

Figure 4 Kaplan-Meier curves of distant recurrence-free survival 0 timepoint=2 years after surgery. SD at 3 years: tamoxifen=0·76, anastrozole=0·52. The Lancet 2005 366, 455-462DOI: (10.1016/S0140-6736(05)67059-6) Copyright © 2005 Elsevier Ltd Terms and Conditions